JEREMIAH HAYS: Open Payments
NPI 1306499520 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,993 in 99 payments from 16 companies in 2025. Trend: 2023 $590 · 2024 $217 · 2025 $1,993
Food & beverage: $1,908Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $654 |
| Janssen Biotech, Inc. | 10 | $254 |
| Aimmune Therapeutics, Inc. | 11 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $193 |
| Celltrion USA Inc. | 6 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Ardelyx, Inc. | 4 | $68 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Medtronic, Inc. | 1 | $57 |
| Lilly USA, LLC | 3 | $56 |
Products named: RINVOQ, TREMFYA, ENTYVIO, SKYRIZI, ZENPEP, LINZESS, VEGZELMA, XIFAXAN.
Industry payments across MO — which companies pay providers there.
